Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RenovoRx (RNXT) Accumulated Expenses (2024 - 2025)

RenovoRx (RNXT) has disclosed Accumulated Expenses for 2 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 12.09% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, down 12.09% year-over-year, with the annual reading at $1.2 million for FY2025, 12.09% down from the prior year.
  • Accumulated Expenses hit $1.2 million in Q4 2025 for RenovoRx, up from $449000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.3 million in Q4 2024 to a low of $45000.0 in Q1 2024.